Aemetis, Inc. (NASDAQ:AMTX) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Aemetis, Inc. (NASDAQ:AMTX) has been assigned a consensus recommendation of “Moderate Buy” from the five ratings firms that are covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $12.95.

A number of research firms have recently commented on AMTX. Ascendiant Capital Markets lowered their target price on Aemetis from $20.00 to $19.00 and set a “buy” rating on the stock in a research note on Tuesday, September 3rd. UBS Group dropped their target price on shares of Aemetis from $8.25 to $7.75 and set a “buy” rating on the stock in a research note on Monday, August 19th. HC Wainwright reissued a “buy” rating and set a $28.00 target price on shares of Aemetis in a research report on Friday, August 2nd. Truist Financial reaffirmed a “hold” rating and issued a $3.50 price target (down previously from $4.00) on shares of Aemetis in a report on Wednesday, July 31st. Finally, StockNews.com raised Aemetis to a “sell” rating in a report on Wednesday, July 31st.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. SG Americas Securities LLC bought a new stake in Aemetis during the 1st quarter valued at $60,000. Hutchinson Capital Management CA bought a new stake in shares of Aemetis during the 2nd quarter valued at $70,000. State Board of Administration of Florida Retirement System purchased a new stake in Aemetis during the 1st quarter worth about $84,000. Rhumbline Advisers boosted its stake in Aemetis by 2,837.1% in the 2nd quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock worth $157,000 after purchasing an additional 50,528 shares during the period. Finally, Bank of New York Mellon Corp purchased a new position in Aemetis during the 2nd quarter valued at about $306,000. 27.02% of the stock is owned by institutional investors.

Aemetis Stock Performance

Shares of AMTX stock opened at $2.40 on Friday. Aemetis has a 52-week low of $2.10 and a 52-week high of $7.03. The company has a 50-day simple moving average of $2.64 and a two-hundred day simple moving average of $3.42. The company has a market capitalization of $106.56 million, a price-to-earnings ratio of -2.05 and a beta of 1.25.

Aemetis (NASDAQ:AMTX) last issued its quarterly earnings results on Thursday, August 1st. The specialty chemicals company reported ($0.66) EPS for the quarter, missing analysts’ consensus estimates of ($0.41) by ($0.25). The company had revenue of $66.56 million during the quarter, compared to the consensus estimate of $75.37 million. During the same period last year, the firm earned ($0.68) earnings per share. On average, sell-side analysts forecast that Aemetis will post -2.19 EPS for the current fiscal year.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.